Core Viewpoint - Veeva Systems Inc. (NYSE: VEEV) is gaining attention as a strong investment opportunity due to its cloud-based software solutions for the life sciences industry, particularly in the context of AI integration and CRM capabilities for pharmaceutical companies [1][2] Group 1: Company Overview - Veeva Systems provides cloud-based software specifically designed for the life sciences sector, covering areas from research and development to commercialization [2] - The company has developed its own CRM platform, Vault CRM, after significant capital expenditure, moving away from reliance on Salesforce [1] Group 2: Financial Performance - Veeva Systems is projected to have its most profitable year in absolute dollar terms since 2020, driven by substantial investments and large deals with major pharmaceutical and biotech companies [2] - The company reported revenue and earnings that exceeded expectations, marking some of the strongest results in its history, with commercial subscription revenue growth accelerated by the Crossix platform [2] Group 3: Market Position and Future Outlook - Veeva is becoming the industry standard CRM platform for drug discovery, with notable partnerships including Bristol Myers [1] - The company is not widely known yet is increasing its market share, and while it is not considered a cheap stock, its fundamentals and operating margins are viewed positively [2]

Core Insights - TimesSquare Capital Management's "U.S. Focus Growth Strategy" reported strong performance in Q2 2025, with equities achieving double-digit returns as global economic activity expanded [1] - Growth indexes outperformed value counterparts, with U.S. small and mid-cap growth indexes showing better returns from stocks with high valuations, negative earnings, or low returns on equity [1] - The strategy returned 11.79% (gross) and 11.56% (net), compared to an 18.20% return for the Russell Midcap Growth Index [1] Company Focus: Veeva Systems Inc. (NYSE:VEEV) - Veeva Systems Inc. reported a one-month return of -0.14% and a 52-week gain of 24.85%, with a market capitalization of $45.009 billion as of September 10, 2025 [2] - The strategy received a 24% boost from Veeva Systems, which surpassed revenue and earnings expectations, achieving total revenue of $789 million [3][4] - Veeva's commercial subscription revenue growth accelerated, driven by its Crossix platform, and new AI-embedded features were announced for its Vault suite [3] Hedge Fund Interest - Veeva Systems was held by 61 hedge fund portfolios at the end of Q2 2025, an increase from 55 in the previous quarter [4] - Despite strong results, the company is not among the 30 most popular stocks among hedge funds, with some analysts suggesting other AI stocks may offer greater upside potential [4]